Asymmetry Capital Management: Funding, Team & Investors | Startup Intros

Loading organizations...

Asymmetry Capital Management: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Aug 1, 2021	Dice Therapeutics	$60.0M Series C	RA Capital Management, Sands Capital	RA Capital, Samsara BioCapital, Versant Ventures, Deep Track Capital, Driehaus Capital Management, Eventide Asset Management, Janus Henderson Investors, Logos Capital, New Leaf Venture Partners, Northpond Ventures, Osage University Partners, Soleus Capital
Jan 1, 2021	Dice Therapeutics	$80.0M Series C	Jake Simson	RA Capital, Samsara BioCapital, Versant Ventures, Agent Capital, Alexandria Venture Investments, Altitude Life Science Ventures, Driehaus Capital Management, Eventide Asset Management, New Leaf Venture Partners, Northpond Ventures, Osage University Partners, Sands Capital, Sanofi Ventures, Soleus Capital
Sep 29, 2020	Galecto	$64.0M Other Equity	Stephan Christgau, Guy Levy	Bristol Myers Squibb, Canica, Cormorant Asset Management, Hans Schambye, Hadean Ventures, HBM Healthcare Investments, Janus Henderson Investors, Maverick Ventures, Novo Holdings, OrbiMed, Seventure Partners, Sphera, Sunstone Capital, Ysios Capital